Showing results 14 to 18 of 18
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2021 | |||
Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International | 2022 | ||
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold Proceeding/Conference:Journal of Hepatology | 2019 | ||
2020 | |||
Update of the statements on biology and clinical impact of occult hepatitis B virus infection Journal:Journal of Hepatology | Raimondo, GLocarnini, SPollicino, TLevrero, MZoulim, FLok, ASAllain, JPBerg, TBertoletti, ABrunetto, MRBruno, RChen, DSCoppola, NCornberg, MCraxì, ADandri, MDi Marco, VFerrari, CGaeta, GBGlebe, DGuidotti, LGKramvis, ALampertico, PLi, CLiang, JMarzano, AMichalak, TIPawlotsky, JMPrati, DPuoti, MSamuel, DSoriano, VSquadrito, GSureau, CTrepo, CYuen, MF | 2019 |